| Current concepts in the diagnosis and management of cytokine release syndrome DW Lee, R Gardner, DL Porter, CU Louis, N Ahmed, M Jensen, SA Grupp, ... Blood, The Journal of the American Society of Hematology 124 (2), 188-195, 2014 | 2836 | 2014 |
| ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells DW Lee, BD Santomasso, FL Locke, A Ghobadi, CJ Turtle, JN Brudno, ... Biology of blood and marrow transplantation 25 (4), 625-638, 2019 | 2272 | 2019 |
| Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults RA Gardner, O Finney, C Annesley, H Brakke, C Summers, K Leger, ... Blood, The Journal of the American Society of Hematology 129 (25), 3322-3331, 2017 | 1051 | 2017 |
| Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy R Gardner, D Wu, S Cherian, M Fang, LA Hanafi, O Finney, H Smithers, ... Blood, The Journal of the American Society of Hematology 127 (20), 2406-2410, 2016 | 750 | 2016 |
| CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity E Jacoby, SM Nguyen, TJ Fountaine, K Welp, B Gryder, H Qin, Y Yang, ... Nature communications 7 (1), 12320, 2016 | 412 | 2016 |
| Fine tuning of TCR signaling by CD5 HS Azzam, JB DeJarnette, K Huang, R Emmons, CS Park, CL Sommers, ... The Journal of Immunology 166 (9), 5464-5472, 2001 | 363 | 2001 |
| CD19 CAR T cell product and disease attributes predict leukemia remission durability OC Finney, H Brakke, S Rawlings-Rhea, R Hicks, D Doolittle, M Lopez, ... The Journal of clinical investigation 129 (5), 2123-2132, 2019 | 287 | 2019 |
| Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells S Terakura, TN Yamamoto, RA Gardner, CJ Turtle, MC Jensen, ... Blood, The Journal of the American Society of Hematology 119 (1), 72-82, 2012 | 251 | 2012 |
| Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy RA Gardner, F Ceppi, J Rivers, C Annesley, C Summers, A Taraseviciute, ... Blood, The Journal of the American Society of Hematology 134 (24), 2149-2158, 2019 | 247 | 2019 |
| Chimeric antigen receptor T cell–mediated neurotoxicity in nonhuman primates A Taraseviciute, V Tkachev, R Ponce, CJ Turtle, JM Snyder, HD Liggitt, ... Cancer discovery 8 (6), 750-763, 2018 | 222 | 2018 |
| Outcome of infants younger than 1 year with acute lymphoblastic leukemia treated with the interfant-06 protocol: results from an international phase III randomized study R Pieters, P De Lorenzo, P Ancliffe, LA Aversa, B Brethon, A Biondi, ... Journal of clinical oncology 37 (25), 2246-2256, 2019 | 220 | 2019 |
| Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis NA Vitanza, AJ Johnson, AL Wilson, C Brown, JK Yokoyama, A Künkele, ... Nature medicine 27 (9), 1544-1552, 2021 | 174 | 2021 |
| Specific requirement for CD3ɛ in T cell development JB DeJarnette, CL Sommers, K Huang, KJ Woodside, R Emmons, K Katz, ... Proceedings of the National Academy of Sciences 95 (25), 14909-14914, 1998 | 158 | 1998 |
| Glial injury in neurotoxicity after pediatric CD19‐directed chimeric antigen receptor T cell therapy J Gust, OC Finney, D Li, HM Brakke, RM Hicks, RB Futrell, DN Gamble, ... Annals of neurology 86 (1), 42-54, 2019 | 145 | 2019 |
| Blinatumomab nonresponse and high-disease burden are associated with inferior outcomes after CD19-CAR for B-ALL RM Myers, A Taraseviciute, SM Steinberg, AJ Lamble, J Sheppard, ... Journal of Clinical Oncology 40 (9), 932, 2022 | 129 | 2022 |
| Outcomes of adults and children with primary mediastinal B‐cell lymphoma treated with dose‐adjusted EPOCH‐R L Giulino‐Roth, T O'Donohue, Z Chen, NL Bartlett, A LaCasce, ... British journal of haematology 179 (5), 739-747, 2017 | 127 | 2017 |
| CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL) SK Tasian, RA Gardner Therapeutic advances in hematology 6 (5), 228-241, 2015 | 120 | 2015 |
| Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study W Sun, J Malvar, R Sposto, A Verma, JJ Wilkes, R Dennis, K Heym, ... Leukemia 32 (11), 2316-2325, 2018 | 117 | 2018 |
| Infectious complications following CD19 chimeric antigen receptor T-cell therapy for children, adolescents, and young adults SB Vora, A Waghmare, JA Englund, P Qu, RA Gardner, JA Hill Open forum infectious diseases 7 (5), ofaa121, 2020 | 108 | 2020 |
| Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells DA Lichtenstein, F Schischlik, L Shao, SM Steinberg, B Yates, HW Wang, ... Blood, The Journal of the American Society of Hematology 138 (24), 2469-2484, 2021 | 107 | 2021 |
